Roche (RO.SW,ROG.SW) announced that the cobas MPX-E assay, a qualitative in-vitro test for the detection and discrimination of Human Immunodeficiency Virus and Hepatitis C, B, and E viruses, is now available in countries accepting the CE mark. The new test delivers faster turnaround times and allows labs to implement Hepatitis E screening without requiring additional instrumentation.
The company said the assay runs on the fully automated cobas x800 systems, which are already used by laboratories worldwide to run more than 10 million tests per month.
At last close, shares of Roche were trading at 312.50 Swiss francs.
For More Such Health News, visit rttnews.com.
For comments and feedback contact: editorial@rttnews.com
Business News
May 15, 2026 15:25 ET Apart from the confirmation of Kevin Warsh as the next Fed chair, the main news on the economics front this week included key price data from the U.S. and the first quarter economic growth figures from major economies. Both consumer prices and producer costs have started to reflect the effect of supply shocks due to the Middle East conflict. In Europe, GDP data was in focus, while inflation data from China dominated the news flow in Asia.